English ticker view

AVBP

ARRIVENT BIOPHARMA INC

This page combines public comments, SEC 13F holdings, insider trades, and simple return calculations for one ticker. Use the original source links before making your own decision.

Full Korean data view Search another ticker

Current price

$35.10

Public comments

13F holding rows

Insider trade rows

Public comments

Ranked by current return where prices are available.

13F direction

24 / 16

New or increased positions vs reduced or sold positions.

Insider activity

0 buyers

Based on SEC Form 4 market purchase and sale rows.

Latest comments

Most recent public records

No public comment records are connected to this ticker yet.

SEC 13F

Institution holding changes

Brevan Howard Capital Management LP

sold out · May 15, 2026

+74.5%

Filing price $20.12 · Current $35.10

AllianceBernstein L.P.

unchanged · May 15, 2026

+74.5%

Filing price $20.12 · Current $35.10

JPMorgan Chase & Co.

sold out · May 13, 2026

+67.1%

Filing price $21.01 · Current $35.10

Dimensional Fund Advisors LP

increased · May 7, 2026

+52.2%

Filing price $23.0624 · Current $35.10

Optiver Holding B.V.

unchanged · May 15, 2026

+52.1%

Filing price $23.0698 · Current $35.10

Citigroup Inc

decreased · May 11, 2026

+52.1%

Filing price $23.0699 · Current $35.10

Wells Fargo & Company

decreased · May 11, 2026

+52.1%

Filing price $23.0699 · Current $35.10

Legal & General Group Plc

decreased · May 8, 2026

+52.1%

Filing price $23.07 · Current $35.10

Insider trades

SEC Form 4 summary

No insider summary is connected to this ticker yet.

Information only. WhenBuy summarizes public data and simple calculations. It is not a stock recommendation, and returns may not reflect dividends, taxes, FX rates, fees, splits, or exact trade timing.